Biotin-Linked Ursolic Acid Conjugates as Selective Anticancer Agents and Target-Identification Tools for Cancer Therapy
Molecules · 28.11.2025 · 30 (23) · 4588
DOI: 10.3390/molecules30234588 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 28.11.2025. Verfasst von Riham M Bokhtia und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt. Hauptthemen laut MEDLINE: Triterpenes, Biotin, Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: United States Department of Defense, J. Harold Harrison Endowment Fund, Department of Defense.
Abstract (Originalsprache)
Ursolic acid (UA), a naturally occurring pentacyclic triterpenoid, exhibits potent anticancer properties; however, its poor solubility and bioavailability limit its therapeutic application. To overcome these challenges and facilitate molecular target identification, a set of biotin-conjugated UA derivatives (5a–d) was synthesized through selective C-28 alkylation and biotinylation. The use of microwave-assisted synthesis significantly enhanced both reaction efficiency and product purity. Among the derivatives, compound 5c exhibited increased cytotoxicity and selectivity against bladder cancer cell lines, surpassing UA in its ability to induce apoptosis, generate reactive oxygen species (ROS), and halt cell cycle progression at the G1 phase. Proteomic profiling revealed that 5c interacts with proteins involved in ER stress, RNA processing, cytoskeletal remodeling, and metabolic regulation. These findings underscore the potential of biotinylated UA derivatives as multifunctional chemical probes for mechanistic studies in the development of targeted therapies for cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt.
- Georgia Cancer Center, Augusta University, Augusta, GA 30912, USA.
- Department of Chemistry and Biochemistry, Augusta University, Augusta, GA 30912, USA.
- Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA 30332, USA.
- Department of Chemistry, University of Delhi, New Delhi, Delhi 110007, India.
- Department of Chemistry, Birla Institute of Technology and Science, Pilani, Rajasthan 333031, India.
ORCID-Profile: Riham M Bokhtia, Kunj Bihari Gupta, Theerth Vikas Srinivasan, Sophia Ying, Guido F Verbeck, Bal L Lokeshwar
Förderung
- United States Department of Defense
- J. Harold Harrison Endowment Fund
- Department of Defense
- Georgia Cancer Center
Zitieren
APA
Bokhtia, R. M., Gupta, K. B., Natalini, A., Srinivasan, T. V., Amineni, N., Ying, S., Shakuja, R., Verbeck, G. F., Lokeshwar, B. L., & Panda, S. S. (2025). Biotin-Linked Ursolic Acid Conjugates as Selective Anticancer Agents and Target-Identification Tools for Cancer Therapy. Molecules, 30(23), 4588. https://doi.org/10.3390/molecules30234588
Vancouver
Bokhtia RM, Gupta KB, Natalini A, Srinivasan TV, Amineni N, Ying S, et al. Biotin-Linked Ursolic Acid Conjugates as Selective Anticancer Agents and Target-Identification Tools for Cancer Therapy. Molecules. 2025;30(23):4588. doi:10.3390/molecules30234588
BibTeX
@article{Bokhtia2025,
author = {Bokhtia, Riham M and Gupta, Kunj Bihari and Natalini, Annabella and Srinivasan, Theerth Vikas and Amineni, Nihal and Ying, Sophia and Shakuja, Rajeev and Verbeck, Guido F and Lokeshwar, Bal L and Panda, Siva S},
title = {Biotin-Linked Ursolic Acid Conjugates as Selective Anticancer Agents and Target-Identification Tools for Cancer Therapy},
journal = {Molecules},
year = {2025},
volume = {30},
number = {23},
pages = {4588},
doi = {10.3390/molecules30234588}
}
EUVIMED